Affiliation:
1. Department of Biomedical Engineering, University of Illinois Chicago, Chicago, IL 60607, USA
2. Division of Gastroenterology & Hepatology, University of Illinois Chicago, Chicago, IL 60612, USA
3. Jesse Brown VA Medical Center, Chicago, IL 60612, USA
Abstract
Serotonin transporter (SERT) deficiency has been implicated in metabolic syndrome, intestinal inflammation, and microbial dysbiosis. Interestingly, changes in microbiome metabolic capacity and several alterations in host gene expression, including lipid metabolism, were previously observed in SERT−/− mice ileal mucosa. However, the precise host or microbial metabolites altered by SERT deficiency that may contribute to the pleiotropic phenotype of SERT KO mice are not yet understood. This study investigated the hypothesis that SERT deficiency impacts lipid and microbial metabolite abundances in the ileal mucosa, where SERT is highly expressed. Ileal mucosal metabolomics was performed by Metabolon on wild-type (WT) and homozygous SERT knockout (KO) mice. Fluorescent-activated cell sorting (FACS) was utilized to measure immune cell populations in ileal lamina propria to assess immunomodulatory effects caused by SERT deficiency. SERT KO mice exhibited a unique ileal mucosal metabolomic signature, with the most differentially altered metabolites being lipids. Such changes included increased diacylglycerols and decreased monoacylglycerols in the ileal mucosa of SERT KO mice compared to WT mice. Further, the ileal mucosa of SERT KO mice exhibited several changes in microbial-related metabolites known to play roles in intestinal inflammation and insulin resistance. SERT KO mice also had a significant reduction in the abundance of ileal group 3 innate lymphoid cells (ILC3). In conclusion, SERT deficiency induces complex alterations in the ileal mucosal environment, indicating potential links between serotonergic signaling, gut microbiota, mucosal immunity, intestinal inflammation, and metabolic syndrome.
Funder
National Institutes of Health
Crohn's and Colitis Foundation
United States Department of Veterans Affairs
Reference72 articles.
1. Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance;Terry;Handbook of Experimental Pharmacology,2017
2. 5-Hydroxytryptamine (Serotonin) in the Gastrointestinal Tract;Gershon;Curr. Opin. Endocrinol. Diabetes Obes.,2013
3. Koopman, N., Katsavelis, D., Hove, A.S.T., Brul, S., de Jonge, W.J., and Seppen, J. (2021). The Multifaceted Role of Serotonin in Intestinal Homeostasis. Int. J. Mol. Sci., 22.
4. Emerging Roles of Gut Serotonin in Regulation of Immune Response, Microbiota Composition and Intestinal Inflammation;Grondin;J. Can. Assoc. Gastroenterol.,2024
5. A Population of Gut Epithelial Enterochromaffin Cells Is Mechanosensitive and Requires Piezo2 to Convert Force into Serotonin Release;Alcaino;Proc. Natl. Acad. Sci. USA,2018